 Particularly, PANX2 expression levels predict post diagnosis survival for patients with glial tumors.Probenecid, a well-established drug for the treatment of gout, allows for discrimination between channels formed by connexins and pannexins.Probenecid did not affect channels formed by connexins, but it inhibits pannexin-1 channels.